 | • レポートコード：MRC2-11QY08386 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はオピオイド誘発性便秘（OIC）治療薬のグローバル市場について調査・分析したレポートです。種類別（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オピオイド誘発性便秘（OIC）治療薬の競争状況、市場シェア ・世界のオピオイド誘発性便秘（OIC）治療薬市場：種類別市場規模 2015年-2020年（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他） ・世界のオピオイド誘発性便秘（OIC）治療薬市場：種類別市場規模予測 2021年-2026年（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他） ・世界のオピオイド誘発性便秘（OIC）治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のオピオイド誘発性便秘（OIC）治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のオピオイド誘発性便秘（OIC）治療薬市場分析：米国、カナダ ・ヨーロッパのオピオイド誘発性便秘（OIC）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオピオイド誘発性便秘（OIC）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオピオイド誘発性便秘（OIC）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオピオイド誘発性便秘（OIC）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ironwood Pharmaceuticals、Daiichi Sankyo Co、Pfizer、Progenics Pharmaceuticals、Shionogi &、Allergan、Nektar Therapeutics、Purdue Pharma、S.L.A. Pharma、Mundipharma International Limited、Ono Pharmaceutical、Takeda Pharmaceutical Company Limited、Theravance Biopharma、Bausch Health、Cosmo Pharmaceuticals SA、Daewoong Pharmaceutical、C.B. Fleet Company、Sucampo Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas.
Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drug Market
The global Opioid Induced Constipation (OIC) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Opioid Induced Constipation (OIC) Drug Scope and Market Size
Opioid Induced Constipation (OIC) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Opioid Induced Constipation (OIC) Drug market is segmented into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Segment by Application, the Opioid Induced Constipation (OIC) Drug market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Opioid Induced Constipation (OIC) Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Opioid Induced Constipation (OIC) Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Opioid Induced Constipation (OIC) Drug Market Share Analysis
Opioid Induced Constipation (OIC) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioid Induced Constipation (OIC) Drug business, the date to enter into the Opioid Induced Constipation (OIC) Drug market, Opioid Induced Constipation (OIC) Drug product introduction, recent developments, etc.
The major vendors covered:
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drug Product Introduction
1.2 Market Segments
1.3 Key Opioid Induced Constipation (OIC) Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size, Estimates and Forecasts
2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2015-2026
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2015-2026
2.2 Global Opioid Induced Constipation (OIC) Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Opioid Induced Constipation (OIC) Drug Competitor Landscape by Players
3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2015-2020)
3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2015-2020)
3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drug Revenue in 2019
3.2.5 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers
3.4 Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2015-2020)
4.1.3 Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2021-2026)
4.2.3 Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Opioid Induced Constipation (OIC) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020)
5.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020)
5.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2015-2020)
5.1.3 Opioid Induced Constipation (OIC) Drug Price by Application (2015-2020)
5.2 Opioid Induced Constipation (OIC) Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Opioid Induced Constipation (OIC) Drug by Country
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Country
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
6.3 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drug by Country
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
7.3 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug by Region
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Opioid Induced Constipation (OIC) Drug by Country
9.1.1 Latin America Opioid Induced Constipation (OIC) Drug Sales by Country
9.1.2 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
9.3 Central & South America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Country
10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country
10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Corporation Information
11.1.2 Ironwood Pharmaceuticals Description and Business Overview
11.1.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.1.5 Ironwood Pharmaceuticals Related Developments
11.2 Daiichi Sankyo Co
11.2.1 Daiichi Sankyo Co Corporation Information
11.2.2 Daiichi Sankyo Co Description and Business Overview
11.2.3 Daiichi Sankyo Co Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Products Offered
11.2.5 Daiichi Sankyo Co Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Products Offered
11.3.5 Pfizer Related Developments
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Corporation Information
11.4.2 Progenics Pharmaceuticals Description and Business Overview
11.4.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.4.5 Progenics Pharmaceuticals Related Developments
11.5 Shionogi &
11.5.1 Shionogi & Corporation Information
11.5.2 Shionogi & Description and Business Overview
11.5.3 Shionogi & Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Products Offered
11.5.5 Shionogi & Related Developments
11.6 Allergan
11.6.1 Allergan Corporation Information
11.6.2 Allergan Description and Business Overview
11.6.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Allergan Opioid Induced Constipation (OIC) Drug Products Offered
11.6.5 Allergan Related Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Corporation Information
11.7.2 Nektar Therapeutics Description and Business Overview
11.7.3 Nektar Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Products Offered
11.7.5 Nektar Therapeutics Related Developments
11.8 Purdue Pharma
11.8.1 Purdue Pharma Corporation Information
11.8.2 Purdue Pharma Description and Business Overview
11.8.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.8.5 Purdue Pharma Related Developments
11.9 S.L.A. Pharma
11.9.1 S.L.A. Pharma Corporation Information
11.9.2 S.L.A. Pharma Description and Business Overview
11.9.3 S.L.A. Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.9.5 S.L.A. Pharma Related Developments
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Corporation Information
11.10.2 Mundipharma International Limited Description and Business Overview
11.10.3 Mundipharma International Limited Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Products Offered
11.10.5 Mundipharma International Limited Related Developments
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Corporation Information
11.1.2 Ironwood Pharmaceuticals Description and Business Overview
11.1.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.1.5 Ironwood Pharmaceuticals Related Developments
11.12 Takeda Pharmaceutical Company Limited
11.12.1 Takeda Pharmaceutical Company Limited Corporation Information
11.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
11.12.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Takeda Pharmaceutical Company Limited Products Offered
11.12.5 Takeda Pharmaceutical Company Limited Related Developments
11.13 Theravance Biopharma
11.13.1 Theravance Biopharma Corporation Information
11.13.2 Theravance Biopharma Description and Business Overview
11.13.3 Theravance Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Theravance Biopharma Products Offered
11.13.5 Theravance Biopharma Related Developments
11.14 Bausch Health
11.14.1 Bausch Health Corporation Information
11.14.2 Bausch Health Description and Business Overview
11.14.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Bausch Health Products Offered
11.14.5 Bausch Health Related Developments
11.15 Cosmo Pharmaceuticals SA
11.15.1 Cosmo Pharmaceuticals SA Corporation Information
11.15.2 Cosmo Pharmaceuticals SA Description and Business Overview
11.15.3 Cosmo Pharmaceuticals SA Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Cosmo Pharmaceuticals SA Products Offered
11.15.5 Cosmo Pharmaceuticals SA Related Developments
11.16 Daewoong Pharmaceutical
11.16.1 Daewoong Pharmaceutical Corporation Information
11.16.2 Daewoong Pharmaceutical Description and Business Overview
11.16.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Daewoong Pharmaceutical Products Offered
11.16.5 Daewoong Pharmaceutical Related Developments
11.17 C.B. Fleet Company
11.17.1 C.B. Fleet Company Corporation Information
11.17.2 C.B. Fleet Company Description and Business Overview
11.17.3 C.B. Fleet Company Sales, Revenue and Gross Margin (2015-2020)
11.17.4 C.B. Fleet Company Products Offered
11.17.5 C.B. Fleet Company Related Developments
11.18 Sucampo Pharmaceuticals
11.18.1 Sucampo Pharmaceuticals Corporation Information
11.18.2 Sucampo Pharmaceuticals Description and Business Overview
11.18.3 Sucampo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Sucampo Pharmaceuticals Products Offered
11.18.5 Sucampo Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Opioid Induced Constipation (OIC) Drug Market Estimates and Projections by Region
12.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2021-2026
12.2 North America Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.2.1 North America: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.2.2 North America: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.2.3 North America: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.3.2 Europe: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Opioid Induced Constipation (OIC) Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioid Induced Constipation (OIC) Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Opioid Induced Constipation (OIC) Drug Market Segments
Table 2. Ranking of Global Top Opioid Induced Constipation (OIC) Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Lubiprostone
Table 5. Major Manufacturers of Methyl Naltrexone Bromide
Table 6. Major Manufacturers of Naldemedine
Table 7. Major Manufacturers of Alvimopan
Table 8. Major Manufacturers of Other
Table 9. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2015-2020 (K Units)
Table 12. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Opioid Induced Constipation (OIC) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2019)
Table 18. Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2015-2020) (USD/Unit)
Table 21. Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
Table 23. Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 26. Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2015-2020)
Table 27. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2015-2020)
Table 29. Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 31. Global Opioid Induced Constipation (OIC) Drug Sales Share by Application (2015-2020)
Table 32. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 33. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 34. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 37. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 38. North America Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 39. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 41. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 45. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 47. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 57. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 61. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 63. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 72. Ironwood Pharmaceuticals Corporation Information
Table 73. Ironwood Pharmaceuticals Description and Major Businesses
Table 74. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Ironwood Pharmaceuticals Product
Table 76. Ironwood Pharmaceuticals Recent Development
Table 77. Daiichi Sankyo Co Corporation Information
Table 78. Daiichi Sankyo Co Description and Major Businesses
Table 79. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Daiichi Sankyo Co Product
Table 81. Daiichi Sankyo Co Recent Development
Table 82. Pfizer Corporation Information
Table 83. Pfizer Description and Major Businesses
Table 84. Pfizer Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Pfizer Product
Table 86. Pfizer Recent Development
Table 87. Progenics Pharmaceuticals Corporation Information
Table 88. Progenics Pharmaceuticals Description and Major Businesses
Table 89. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Progenics Pharmaceuticals Product
Table 91. Progenics Pharmaceuticals Recent Development
Table 92. Shionogi & Corporation Information
Table 93. Shionogi & Description and Major Businesses
Table 94. Shionogi & Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Shionogi & Product
Table 96. Shionogi & Recent Development
Table 97. Allergan Corporation Information
Table 98. Allergan Description and Major Businesses
Table 99. Allergan Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Allergan Product
Table 101. Allergan Recent Development
Table 102. Nektar Therapeutics Corporation Information
Table 103. Nektar Therapeutics Description and Major Businesses
Table 104. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Nektar Therapeutics Product
Table 106. Nektar Therapeutics Recent Development
Table 107. Purdue Pharma Corporation Information
Table 108. Purdue Pharma Description and Major Businesses
Table 109. Purdue Pharma Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Purdue Pharma Product
Table 111. Purdue Pharma Recent Development
Table 112. S.L.A. Pharma Corporation Information
Table 113. S.L.A. Pharma Description and Major Businesses
Table 114. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. S.L.A. Pharma Product
Table 116. S.L.A. Pharma Recent Development
Table 117. Mundipharma International Limited Corporation Information
Table 118. Mundipharma International Limited Description and Major Businesses
Table 119. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Mundipharma International Limited Product
Table 121. Mundipharma International Limited Recent Development
Table 122. Ono Pharmaceutical Corporation Information
Table 123. Ono Pharmaceutical Description and Major Businesses
Table 124. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Ono Pharmaceutical Product
Table 126. Ono Pharmaceutical Recent Development
Table 127. Takeda Pharmaceutical Company Limited Corporation Information
Table 128. Takeda Pharmaceutical Company Limited Description and Major Businesses
Table 129. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Takeda Pharmaceutical Company Limited Product
Table 131. Takeda Pharmaceutical Company Limited Recent Development
Table 132. Theravance Biopharma Corporation Information
Table 133. Theravance Biopharma Description and Major Businesses
Table 134. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. Theravance Biopharma Product
Table 136. Theravance Biopharma Recent Development
Table 137. Bausch Health Corporation Information
Table 138. Bausch Health Description and Major Businesses
Table 139. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. Bausch Health Product
Table 141. Bausch Health Recent Development
Table 142. Cosmo Pharmaceuticals SA Corporation Information
Table 143. Cosmo Pharmaceuticals SA Description and Major Businesses
Table 144. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 145. Cosmo Pharmaceuticals SA Product
Table 146. Cosmo Pharmaceuticals SA Recent Development
Table 147. Daewoong Pharmaceutical Corporation Information
Table 148. Daewoong Pharmaceutical Description and Major Businesses
Table 149. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 150. Daewoong Pharmaceutical Product
Table 151. Daewoong Pharmaceutical Recent Development
Table 152. C.B. Fleet Company Corporation Information
Table 153. C.B. Fleet Company Description and Major Businesses
Table 154. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 155. C.B. Fleet Company Product
Table 156. C.B. Fleet Company Recent Development
Table 157. Sucampo Pharmaceuticals Corporation Information
Table 158. Sucampo Pharmaceuticals Description and Major Businesses
Table 159. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 160. Sucampo Pharmaceuticals Product
Table 161. Sucampo Pharmaceuticals Recent Development
Table 162. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 163. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Regions (2021-2026)
Table 164. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 165. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 166. North America: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 167. North America: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Europe: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 169. Europe: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Asia Pacific: Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2021-2026) (K Units)
Table 171. Asia Pacific: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 172. Latin America: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 173. Latin America: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Middle East and Africa: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 175. Middle East and Africa: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 177. Key Challenges
Table 178. Market Risks
Table 179. Main Points Interviewed from Key Opioid Induced Constipation (OIC) Drug Players
Table 180. Opioid Induced Constipation (OIC) Drug Customers List
Table 181. Opioid Induced Constipation (OIC) Drug Distributors List
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioid Induced Constipation (OIC) Drug Product Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Lubiprostone Product Picture
Figure 4. Methyl Naltrexone Bromide Product Picture
Figure 5. Naldemedine Product Picture
Figure 6. Alvimopan Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure 13. Global Opioid Induced Constipation (OIC) Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales 2015-2026 (K Units)
Figure 15. Global Opioid Induced Constipation (OIC) Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2019
Figure 18. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region in 2019
Figure 20. Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Opioid Induced Constipation (OIC) Drug Revenue in 2019
Figure 22. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2019
Figure 25. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type in 2019
Figure 27. Global Opioid Induced Constipation (OIC) Drug Market Share by Price Range (2015-2020)
Figure 28. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application in 2019
Figure 30. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application in 2019
Figure 32. North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019
Figure 35. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Figure 41. North America Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Figure 42. Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019
Figure 45. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019
Figure 46. Germany Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Figure 57. Europe Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Figure 58. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region in 2019
Figure 62. China Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Figure 85. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Figure 86. Latin America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019
Figure 89. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Figure 97. Latin America Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Figure 110. North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
オピオイド誘発性便秘（OIC）治療の世界市場（～2026年） Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Opioid-Induced Constipation…- オピオイド誘発性便秘治療の世界市場（～2026年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
- 便秘の世界市場（～2026年） Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing …
- 便秘治療の世界市場（～2026年） Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement. Market Analysis and Insights: Global Constipation Treatment Market The…
- 化学療法誘発性貧血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy Induced Anemia Drug Market The global Chemotherapy Induced Anemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemotherapy Induced Anemia Drug Scope and Market…